Abstract
Background/aim
To assess sarcopenia and dynapenia and their relationship with disease severity and disabilities in PD and to state body composition in PD.
Methods
We conducted a case–control, cross-sectional study that included 70 patients with idiopathic PD and 85 controls. Sarcopenia was defined according to the European Working Group on Sarcopenia in Older People (EWGSOP) criteria. Dynapenia was detected by a handheld dynamometer. Bioimpedance analysis (BIA) was performed, and the SARC-F questionnaire was applied. Disabilities were appointed according to the Katz and Lawton indexes.
Results
Sarcopenia and dynapenia were more prevalent in PD than in controls (50 vs 30.6% and 31.4 vs 17.6%, respectively). Dynapenia was significantly associated with the severity of the disease and disabilities (p = 0.047, p = 0.001); however, sarcopenia was not. The skeletal muscle mass index (SMMI), fat mass index (FMI), and fat-free mass index (FFMI) did not differ between the PD and controls. FMI was lower in the advanced stages of the disease. Higher scores in the SARC-F questionnaire were significantly associated with disabilities and the severity of the disease (p < 0.001, p < 0.001).
Conclusion
Muscle strength was closely associated with the severity of the disease and disabilities in PD, but muscle mass was not. Sarcopenia, defined by the SARC-F questionnaire, was a good predictor of disabilities in PD, while the EWGSOP criteria were not. PD patients have a favorable body composition even in advanced stages of the disease with lower FMI and protected lean mass.
Similar content being viewed by others
References
Shulman LM (2010) Understanding disability in Parkinson's disease. Mov Disord 25:131–135
Lauretani F, Maggio M, Silvestrini C, Nardelli A, Saccavini M, Ceda GP (2012) Parkinson's disease (PD) in the elderly: an example of geriatric syndrome (GS)? Arch Gerontol Geriatr 54:242–246
Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, Topinkova E, Vandewoude M, Zamboni M, European Working Group on Sarcopenia in Older People (2010l) Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing 39:412–423
Janssen I, Baumgartner RN, Ross R, Rosenberg IH, Roubenoff R (2004) Skeletal muscle cutpoints associated with elevated physical disability risk in older men and women. Am J Epidemiol 159:413–421
Lauretani F, Bautmans I, De Vita F et al (2014) Identification and treatment of older persons with sarcopenia. Aging Male 17:199–204
Drey M, Hasmann SE, Krenovsky JP et al (2017) Associations between early markers of Parkinson's disease and sarcopenia. Front Aging Neurosci 9:53
Barichella M, Pinelli G, Iorio L, Cassani E, Valentino A, Pusani C, Ferri V, Bolliri C, Pasqua M, Pezzoli G, Frazzitta G, Cereda E (2016) Sarcopenia and dynapenia in patients with parkinsonism. J Am Med Dir Assoc 17:640–646
Vetrano DL, Pisciotta MS, Laudisio A, Lo Monaco MR, onder G, Brandi V, Fusco D, di Capua B, Ricciardi D, Bernabei R, Zuccalà G (2018) Sarcopenia in Parkinson disease: comparison of different criteria and association with disease severity. J Am Med Dir Assoc 19:523–527
Yazar T, Yazar HO, Zayimoğlu E, Çankaya S (2018 Aug) Incidence of sarcopenia and dynapenia according to stage in patients with idiopathic Parkinson's disease. Neurol Sci 39(8):1415–1421
Tan AH, Hew YC, Lim SY, Ramli NM, Kamaruzzaman SB, Tan MP, Grossmann M, Ang BH, Tan JY, Manap MAAA, Tay TK, Tan SL, New RP, Fadzli F, Yee EJ, Moy FM, Mahadeva S, Lang AE (2018) Altered body composition, sarcopenia, frailty, and their clinico-biological correlates, in Parkinson's disease. Parkinsonism Relat Disord 56:58–64
Janssen I, Heymsfield SB, Baumgartner RN, Ross R (2000) Estimation of skeletal muscle mass by bioelectrical impedance analysis. J Appl Physiol 89:465–471
Malmstrom TK, Morley JE (2013) SARC-F: a simple questionnaire to rapidly diagnose sarcopenia. J Am Med Dir Assoc 14:531–532
Bahat G, Yilmaz O, Kılıç C et al (2018) Performance of SARC-F in regard to sarcopenia definitions, muscle mass and functional measures. J Nutr Health Aging 22:898–903
Folstein MF, Folstein SE, McHugh PR (1975) "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198
Bahat G, Tufan A, Tufan F, Kilic C, Akpinar TS, Kose M, Erten N, Karan MA, Cruz-Jentoft AJ (2016) Cut-off points to identify sarcopenia according to European Working Group on Sarcopenia in Older People (EWGSOP) definition. Clin Nutr 35:1557–1563
Katz S, Akpom CA (1976) Index of ADL. Med Care 14:116–118
Lawton MP, Brody EM (1969) Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 9:179–186
Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression, and mortality. Neurology 17:427–442
Cereda E, Cassani E, Barichella M, Spadafranca A, Caccialanza R, Bertoli S, Battezzati A, Pezzoli G (2012) Low cardiometabolic risk in Parkinson's disease is independent of nutritional status, body composition and fat distribution. Clin Nutr 31:699–704
van der Marck MA, Dicke HC, Uc EY, Kentin ZHA, Borm GF, Bloem BR, Overeem S, Munneke M (2012) Body mass index in Parkinson's disease: a meta-analysis. Parkinsonism Relat Disord 18:263–267
Bernhardt D, Müller HP, Ludolph AC, Dupuis L, Kassubek J (2016) Body fat distribution in Parkinson's disease: an MRI-based body fat quantification study. Parkinsonism Relat Disord 33:84–89
Wills AM, Pérez A, Wang J, Su X, Morgan J, Rajan SS, Leehey MA, Pontone GM, Chou KL, Umeh C, Mari Z, Boyd J, NINDS Exploratory Trials in Parkinson Disease (NET-PD) Investigators (2016) Association between change in body mass index, unified Parkinson's disease rating scale scores, and survival among persons with Parkinson disease: secondary analysis of longitudinal data from NINDS exploratory trials in Parkinson disease long-term study 1. JAMA Neurol 73:321–328
Beyer PL, Palarino MY, Michalek D et al (1995) Weight change and body composition in patients with Parkinson’s disease. J Am Diet Assoc 95:979–983
Warren Olanow C, Kieburtz K, Rascol O, Poewe W, Schapira AH, Emre M, Nissinen H, Leinonen M, Stocchi F, Stalevo Reduction in Dyskinesia Evaluation in Parkinson's Disease (STRIDE-PD) Investigators (2013) Factors predictive of the development of levodopa-induced dyskinesia and wearing-off in Parkinson's disease. Mov Disord 28:1064–1071
Balogun S, Winzenberg T, Wills K, Scott D, Jones G, Aitken D, Callisaya ML (2017) Prospective associations of low muscle mass and function with 10-year falls risk, incident fracture and mortality in community-dwelling older adults. J Nutr Health Aging 21:843–848
Acknowledgments
The authors thank Merve Çalışkan for taking anthropometric measurements of the patients.
Funding
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ozer, F.F., Akın, S., Gultekin, M. et al. Sarcopenia, dynapenia, and body composition in Parkinson’s disease: are they good predictors of disability?: a case–control study. Neurol Sci 41, 313–320 (2020). https://doi.org/10.1007/s10072-019-04073-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-019-04073-1